These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 31164609)
21. Effects of Doxorubicin, Cisplatin, and Tamoxifen on the Metabolic Profile of Human Breast Cancer MCF-7 Cells As Determined by Maria RM; Altei WF; Selistre-de-Araujo HS; Colnago LA Biochemistry; 2017 Apr; 56(16):2219-2224. PubMed ID: 28379688 [TBL] [Abstract][Full Text] [Related]
23. Rhinacanthin-C enhances doxorubicin cytotoxicity via inhibiting the functions of P-glycoprotein and MRP2 in breast cancer cells. Chaisit T; Siripong P; Jianmongkol S Eur J Pharmacol; 2017 Jan; 795():50-57. PubMed ID: 27916559 [TBL] [Abstract][Full Text] [Related]
24. Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer. Tantivejkul K; Vucenik I; Eiseman J; Shamsuddin AM Breast Cancer Res Treat; 2003 Jun; 79(3):301-12. PubMed ID: 12846414 [TBL] [Abstract][Full Text] [Related]
25. Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays. van Tonder A; Joubert AM; Cromarty AD BMC Res Notes; 2015 Feb; 8():47. PubMed ID: 25884200 [TBL] [Abstract][Full Text] [Related]
26. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Plumb JA; Milroy R; Kaye SB Cancer Res; 1989 Aug; 49(16):4435-40. PubMed ID: 2743332 [TBL] [Abstract][Full Text] [Related]
27. Cytotoxic, Antimitotic, and Antiproliferation Studies on Devarajan A; Mohan Maruga Raja MK Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S452-S457. PubMed ID: 29142398 [TBL] [Abstract][Full Text] [Related]
28. Doxorubicin has in vivo toxicological effects on ex vivo cultured mesenchymal stem cells. Oliveira MS; Carvalho JL; Campos AC; Gomes DA; de Goes AM; Melo MM Toxicol Lett; 2014 Jan; 224(3):380-6. PubMed ID: 24291741 [TBL] [Abstract][Full Text] [Related]
29. Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. Angelini A; Ciofani G; Baccante G; Di Febbo C; Carmine DI; Cuccurullo F; Porreca E Anticancer Res; 2007; 27(1A):351-5. PubMed ID: 17352253 [TBL] [Abstract][Full Text] [Related]
30. Selective inhibition of cell proliferation by lycopene in MCF-7 breast cancer cells in vitro: a proteomic analysis. Uppala PT; Dissmore T; Lau BH; Andacht T; Rajaram S Phytother Res; 2013 Apr; 27(4):595-601. PubMed ID: 22718574 [TBL] [Abstract][Full Text] [Related]
31. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells. Prados J; Melguizo C; Rama AR; Ortiz R; Segura A; Boulaiz H; Vélez C; Caba O; Ramos JL; Aránega A Cancer Chemother Pharmacol; 2010 May; 66(1):69-78. PubMed ID: 19771430 [TBL] [Abstract][Full Text] [Related]
32. Effects of Fucoidan and Chemotherapeutic Agent Combinations on Malignant and Non-malignant Breast Cell Lines. Abudabbus A; Badmus JA; Shalaweh S; Bauer R; Hiss D Curr Pharm Biotechnol; 2017; 18(9):748-757. PubMed ID: 29141543 [TBL] [Abstract][Full Text] [Related]
33. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis. Muñoz-Gámez JA; Martín-Oliva D; Aguilar-Quesada R; Cañuelo A; Nuñez MI; Valenzuela MT; Ruiz de Almodóvar JM; De Murcia G; Oliver FJ Biochem J; 2005 Feb; 386(Pt 1):119-25. PubMed ID: 15456408 [TBL] [Abstract][Full Text] [Related]
34. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway. Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209 [TBL] [Abstract][Full Text] [Related]
35. Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization. Lou PJ; Lai PS; Shieh MJ; Macrobert AJ; Berg K; Bown SG Int J Cancer; 2006 Dec; 119(11):2692-8. PubMed ID: 16991130 [TBL] [Abstract][Full Text] [Related]
36. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin. Liu Y; Du F; Chen W; Yao M; Lv K; Fu P Exp Cell Res; 2013 Dec; 319(20):3140-9. PubMed ID: 24012960 [TBL] [Abstract][Full Text] [Related]
37. Liver-targeted doxorubicin: effects on rat regenerating hepatocytes. Di Stefano G; Derenzini M; Kratz F; Lanza M; Fiume L Liver Int; 2004 Jun; 24(3):246-52. PubMed ID: 15189276 [TBL] [Abstract][Full Text] [Related]
38. Alpha-tocopheryl succinate enhances doxorubicin-induced apoptosis in human gastric cancer cells via promotion of doxorubicin influx and suppression of doxorubicin efflux. Zhang X; Peng X; Yu W; Hou S; Zhao Y; Zhang Z; Huang X; Wu K Cancer Lett; 2011 Aug; 307(2):174-81. PubMed ID: 21536373 [TBL] [Abstract][Full Text] [Related]
39. Polyaspartamide-doxorubicin conjugate as potential prodrug for anticancer therapy. Di Meo C; Cilurzo F; Licciardi M; Scialabba C; Sabia R; Paolino D; Capitani D; Fresta M; Giammona G; Villani C; Matricardi P Pharm Res; 2015 May; 32(5):1557-69. PubMed ID: 25366547 [TBL] [Abstract][Full Text] [Related]
40. The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines. Angelini A; Centurione L; Sancilio S; Castellani ML; Conti P; Di Ilio C; Porreca E; Cuccurullo F; Di Pietro R J Biol Regul Homeost Agents; 2011; 25(2):203-11. PubMed ID: 21880209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]